121 related articles for article (PubMed ID: 8695173)
21. The impact of the loco-regional treatment in elderly breast cancer patients: hypo-fractionated exclusive radiotherapy, single institution long-term results.
Chargari C; Kirova YM; Laki F; Savignoni A; Dorval T; Dendale R; Bollet MA; Fourquet A; Campana F;
Breast; 2010 Oct; 19(5):413-6. PubMed ID: 20483616
[TBL] [Abstract][Full Text] [Related]
22. [Hypercalcemia in breast cancer].
Okada Y; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Ikeda K; Usui N; Nakada H; Adachi K; Mukaiyama T
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1468-74. PubMed ID: 6742868
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
[TBL] [Abstract][Full Text] [Related]
24. Recovery from extreme hypercalcaemia.
Warrell RP; Crown JP
Lancet; 1993 Aug; 342(8867):375. PubMed ID: 8101620
[No Abstract] [Full Text] [Related]
25. Idiopathic systemic capillary leak syndrome preceding diagnosis of infiltrating lobular carcinoma of the breast with quiescence during neoadjuvant chemotherapy.
Bencsath KP; Reu F; Dietz J; Hsi ED; Heresi GA
Mayo Clin Proc; 2011 Mar; 86(3):260-1. PubMed ID: 21364118
[No Abstract] [Full Text] [Related]
26. Gallbladder metastases of breast cancer: from clinical-pathological patterns to diagnostic and therapeutic strategy.
Di Vita M; Zanghì A; Lanzafame S; Cavallaro A; Piccolo G; Berretta M; Grosso G; Cappellani A
Clin Ter; 2011; 162(5):451-6. PubMed ID: 22041804
[TBL] [Abstract][Full Text] [Related]
27. Paraendocrine syndromes.
Pierce ST
Curr Opin Oncol; 1993 Jul; 5(4):639-45. PubMed ID: 8364080
[TBL] [Abstract][Full Text] [Related]
28. Management of Premenopausal Women with Neoadjuvant Endocrine Therapy: A Single-Institution Experience.
Barbie TU; Ma C; Margenthaler JA
Ann Surg Oncol; 2015 Nov; 22(12):3861-5. PubMed ID: 25783678
[TBL] [Abstract][Full Text] [Related]
29. Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.
Calais G; Berger C; Descamps P; Chapet S; Reynaud-Bougnoux A; Body G; Bougnoux P; Lansac J; Le Floch O
Cancer; 1994 Aug; 74(4):1283-8. PubMed ID: 8055449
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
[TBL] [Abstract][Full Text] [Related]
31. t(8;16) AML developed subsequent to breast cancer therapy.
Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemia in head and neck squamous-cell carcinoma.
Sridhar KS; Hussein AM
Am J Clin Oncol; 1990 Oct; 13(5):388-93. PubMed ID: 2220659
[TBL] [Abstract][Full Text] [Related]
33. Use of denosumab in parathyroid carcinoma with refractory hypercalcemia.
Tong CV; Hussein Z; Noor NM; Mohamad M; Ng WF
QJM; 2015 Jan; 108(1):49-50. PubMed ID: 25099611
[No Abstract] [Full Text] [Related]
34. Paraneoplastic hypercalcemia in gynecologic malignancy.
Holtz G
Obstet Gynecol Surv; 1980 Mar; 35(3):129-36. PubMed ID: 6987579
[No Abstract] [Full Text] [Related]
35. [Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications].
Gross E; Hannoun-Levi JM; Rouanet P; Houvenaeghel G; Teissier E; Ellis S; Resbeut M; Tallet A; Vaini Cowen V; Azria D; Cowen D
Cancer Radiother; 2010 Dec; 14(8):704-10. PubMed ID: 20674442
[TBL] [Abstract][Full Text] [Related]
36. Metastatic breast cancer presenting as Tolosa-Hunt syndrome.
Harnett AN; Kemp EG; Fraser G
Clin Oncol (R Coll Radiol); 1999; 11(6):407-9. PubMed ID: 10663332
[TBL] [Abstract][Full Text] [Related]
37. [A negative first-line work-up of Raynaud's phenomenon: And what if it were cancer?].
Auboire L; Landy S; Perrot JY; Maïza D; Le Hello C
J Mal Vasc; 2010 Feb; 35(1):35-7. PubMed ID: 19959302
[TBL] [Abstract][Full Text] [Related]
38. [Thyrocalcitonin: therapeutic confirmation in neoplastic hypercalcemia].
Azzoni P; Turco P; Dal Negro R; Govoni P
Clin Ter; 1977 Sep; 82(5):483-8. PubMed ID: 923189
[No Abstract] [Full Text] [Related]
39. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.
Hoebers FJ; Borger JH; Hart AA; Peterse JL; Th EJ; Lebesque JV
Cancer; 2000 Apr; 88(7):1633-42. PubMed ID: 10738222
[TBL] [Abstract][Full Text] [Related]
40. Paraneoplastic hypercalcaemia in ovarian carcinoma.
Allan SG; Lockhart SP; Leonard RC; Smyth JF
Br Med J (Clin Res Ed); 1984 Jun; 288(6432):1714-5. PubMed ID: 6428510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
